PMC7093901_01
A total occlusion of the left anterior descending coronary artery (LAD), high-grade proximal stenosis in the first diagonal branch (90%), and a diffuse atherosclerotic left circumflex coronary artery (LCx) are depicted in RAO caudal (a, b), RAO cranial (c), LAO cranial (d), and LAO caudal (e) projections. RAO = right anterior oblique; LAO = left anterior oblique.
CRIC2020-6738348.001.jpg
PMC7093901_01_CRIC2020-6738348.001.jpg
fig1
Coronary angiography revealed a total occlusion of the left anterior descending artery (LAD), high-grade proximal stenosis in the first diagonal branch (90%), diffuse atherosclerosis of the left circumflex coronary artery (LCx), and moderate-severe stenosis (70%) in the middle of a dominant right coronary artery (RCA) (Figures 1 and 2).
A moderate-severe stenosis (70%) in the middle dominant right coronary artery (RCA) is shown in LAO caudal (a) and RAO cranial (b) projections. RAO = right anterior oblique; LAO = left anterior oblique.
CRIC2020-6738348.002.jpg
PMC7093901_01_CRIC2020-6738348.002.jpg
fig2
Coronary angiography revealed a total occlusion of the left anterior descending artery (LAD), high-grade proximal stenosis in the first diagonal branch (90%), diffuse atherosclerosis of the left circumflex coronary artery (LCx), and moderate-severe stenosis (70%) in the middle of a dominant right coronary artery (RCA) (Figures 1 and 2).
Left coronary angiogram in a RAO cranial projection showing (a) dilatation of the LAD culprit lesion with drug-eluting balloon, (b) post predilatation of the lesion using a SC Artimes balloon, and (c, d) successful drug-eluting balloon angioplasty with a TIMI grade II flow. TIMI = thrombolysis in myocardial infarction study group; RAO = right anterior oblique.
CRIC2020-6738348.003.jpg
PMC7093901_01_CRIC2020-6738348.003.jpg
fig3
Artimes 1.5 x 12 mm at 16 Atm was done, resulting in a TIMI grade II flow. Subsequently, multiple dilatations of the LAD lesion with a drug-eluting balloon 3.5 x 15mm (Blue Medical Paclitaxel-Eluting Balloon at 6 Atm) were performed (Figure 3). Additionally, due to the presence of thrombotic material and no-reflow phenomenon, eptifibatide (a glycoprotein IIb/IIIa inhibitor) and adenosine were administered intracoronary.